be_ixf;ym_202404 d_26; ct_50

Latest Insights on ADGI

erratic biotech stocks This New Strategy Makes Sense of Biotechs’ Erratic Moves I find one type of stock equal parts frustrating and fascinating — biotechs.
ev production supply chain crisis EV Makers Finally Found a Supply Chain Solution Automakers lost control over their supply chains. And they aren’t looking to repeat this mistake with their EV projects.
market moves short-term trading BIG Market Moves Mean BIG Opportunities When the market moves this much, day trading has the potential to be lucrative.
omicron Adagio Therapeutics A Stock-Picking Mutation to Beat the Omicron Threat This is a company that has never made a profit. In fact, it’s never made any money at all. On top of that, analysts expect its per-share losses to double by the end of 2022. Assuming Adagio manages to generate some revenues next year — the market consensus is a minuscule $151 million — it’s already trading at almost 20 times those sales. Why? Because COVID is here to stay … and the search for a response is moving into new areas … quickly.
2022 stock predictions 5 Bold Predictions for 2022 and Beyond These will be the biggest growth themes for 2022.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“I'm very Happy with your services. I hope you don't plan to retire any time soon! My retirement portfolio depends on your expert guidance. Keep up the great work! Thanks.”

- Randy

“At the end of August [2018], my 401K was $659,000. Now, on September 4th [2018], it’s $715,000. My account is up $56,000 in the last 5 days!”

- Warren O

“My portfolio has grown from 275k to almost 900k with only investments made with Banyan Hill.”

- David G. (Member since 2018)

Share This